Search results
Two-punch treatment delivers blood cancer knockout: Study shows drug combo eradicates cancer cells...
Medical Xpress· 7 hours agoThe discovery, published in Cancer Cell, could soon lead to clinical trials, providing hope for the...
First-ever trial over Zantac cancer claims gets underway in Cook County
Chicago Sun-Times· 1 hour agoAn Illinois woman’s lawsuit claiming she developed colorectal cancer from taking the heartburn drug...
Beloved high school football coach, 60, dies due to chemo drug shortage
The Independent via Yahoo News· 2 hours agoJeff Bolle’s death comes amid a devastating shortage of critical chemotherapy drugs, which has left ...
FDA misses own deadline to propose ban on cancer-linked formaldehyde from hair relaxers
NBC NEWS· 36 minutes agoThe proposal had come after wide-ranging studies found an association between some of the...
Johnson & Johnson proposes $6.5B settlement to resolve talc cancer claims
NJBIZ· 3 hours agoJohnson & Johnson hopes to move forward with a $6.48 billion settlement of more than 50,000 lawsuits...
mRNA Brain Cancer Vaccine Shows Promise In Early Trials In Humans – And Dogs
IFLScience· 6 hours agoA new mRNA vaccine candidate for aggressive brain cancer has shown promise in a small clinical trial...
Atossa and Weill Cornell expand breast cancer drug research By Investing.com
Investing.com· 1 day ago(NASDAQ:ATOS), a biopharmaceutical company, announced today an expanded research agreement with...
DEA may reclassify marijuana as a Schedule III drug. What would that mean for Georgia?
The Augusta Chronicle via Yahoo News· 2 hours agoWith a Schedule I drug, depending on the amount of the possession, the punishment could be up to 15 years. Is marijuana legal in Georgia? Georgia...Georgia Low THC Registry ...
Chinese companies lead ADC pipeline
Pharmaceutical Technology via Yahoo Finance· 4 hours agoOne of its drugs, Rina-S, is a potential best-in-class ADC that was granted Fast Track designation by the US Food and Drug Administration in early 2024...
Pfizer and Genmab’s Tivdak wins full FDA approval for cervical cancer
Pharmaceutical Technology via Yahoo Finance· 1 day agoPfizer and Genmab’s Tivdak (tisotumab vedotin-tftv) has won full approval from the US Food and Drug...
